Yasuharu Shinoda Selected Research

Yasuharu Shinoda Research Topics

Disease

5	Parkinson Disease (Parkinson's Disease) 03/2022 - 01/2019
5	Cognitive Dysfunction 01/2020 - 01/2017
4	Brain Ischemia (Cerebral Ischemia) 10/2019 - 10/2015
3	Heart Failure 02/2023 - 01/2016
3	Alzheimer Disease (Alzheimer's Disease) 05/2020 - 01/2017
3	Ischemia 10/2019 - 10/2015
3	Memory Disorders (Memory Loss) 04/2019 - 10/2015
2	Hypertrophy 02/2023 - 07/2016
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2023 - 07/2016
2	Dementia (Dementias) 05/2020 - 01/2017
2	Tobacco Use Disorder (Nicotine Dependence) 12/2019 - 01/2018
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2019 - 01/2018
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 02/2017 - 12/2014
1	Edema (Dropsy) 09/2023
1	Hyperalgesia 09/2023
1	Skin Abnormalities 09/2023
1	Glioblastoma (Glioblastoma Multiforme) 03/2022
1	Melanoma (Melanoma, Malignant) 03/2021
1	Seizures (Absence Seizure) 08/2020
1	Status Epilepticus (Complex Partial Status Epilepticus) 08/2020
1	Synucleinopathies 08/2020
1	Body Weight (Weight, Body) 04/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2019
1	Ischemic Stroke 01/2018
1	Obesity 01/2018
1	Hypothyroidism 01/2018
1	Atherosclerosis 01/2017
1	Schizophrenia (Dementia Praecox) 07/2016

Drug/Important Bio-Agent (IBA)

4	SynucleinsIBA 03/2022 - 01/2019
4	LigandsIBA 03/2021 - 10/2015
3	Sigma-1 ReceptorIBA 02/2023 - 10/2015
3	Fatty Acid Binding Protein 3IBA 03/2022 - 01/2020
3	Adenosine Triphosphate (ATP)IBA 01/2017 - 10/2015
2	Dopamine (Intropin)FDA LinkGeneric 03/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 12/2019 - 01/2018
2	KY-226IBA 10/2019 - 01/2018
2	Neuroprotective AgentsIBA 04/2019 - 01/2018
2	Amyloid beta-PeptidesIBA 02/2019 - 01/2018
2	T-Type Calcium Channels (T-Type Calcium Channel)IBA 02/2019 - 01/2018
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 02/2019 - 10/2015
1	Endothelin-1 (Endothelin 1)IBA 02/2023
1	Arachidonic Acid (Vitamin F)IBA 03/2022
1	CateninsIBA 03/2021
1	Fatty Acid-Binding Protein 7IBA 03/2021
1	LipidsIBA 03/2021
1	Diazepam (Valium)FDA LinkGeneric 08/2020
1	Pilocarpine (Ocusert)FDA LinkGeneric 08/2020
1	Pentylenetetrazole (Metrazol)IBA 08/2020
1	Amyloid (Amyloid Fibrils)IBA 05/2020
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2020
1	Dopamine Receptors (Dopamine Receptor)IBA 12/2019
1	WortmanninIBA 10/2019
1	U 0126 (UO 126)IBA 10/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2019
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 10/2019
1	Docosahexaenoic AcidsIBA 04/2019
1	Cytidine Diphosphate Choline (Citicoline)IBA 04/2019
1	AcetylcholinesteraseIBA 01/2018
1	Nicotine FDA Link 01/2018
1	Methimazole (Thiamazole)FDA LinkGeneric 01/2018
1	methyllycaconitineIBA 01/2018
1	SodiumIBA 01/2018
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	Vanadates (Orthovanadate)IBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Cholinergic Agents (Cholinergics)IBA 01/2018
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2018
1	NNC 55-0396IBA 01/2018
1	DiarylheptanoidsIBA 01/2018
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2018
1	Memantine (Namenda)FDA Link 01/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017
1	Donepezil (Aricept)FDA LinkGeneric 01/2017
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2017
1	Haloperidol (Haldol)FDA LinkGeneric 07/2016
1	Angiotensin IIIBA 07/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016
1	SA 4503IBA 01/2016
1	CorticosteroneIBA 01/2016
1	Dehydroepiandrosterone (DHEA)IBA 10/2015
1	Adenosine (Adenocard)FDA LinkGeneric 10/2015
1	methyl pyruvateIBA 12/2014

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 09/2023
1	Injections 01/2018
1	Therapeutics 01/2016